Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Prometeus's Profile
Displaying 51-100 of 195 result(s).
GNBTQ Generex Biotechnology Corp.
05/27/2021 9:26:40 AM
we are not talking about gifts for (5)
GNBTQ Generex Biotechnology Corp.
05/27/2021 9:17:36 AM
I also thought the same thing 2 yea (1)
GNBTQ Generex Biotechnology Corp.
05/25/2021 10:45:45 AM
one of the unclear steps for me: af
GNBTQ Generex Biotechnology Corp.
05/22/2021 6:58:12 PM
shared desire .. even if utopian. U (1)
GNBTQ Generex Biotechnology Corp.
05/21/2021 1:56:13 PM
you're right, that's not correct. a (3)
GNBTQ Generex Biotechnology Corp.
05/21/2021 10:55:15 AM
we will have a company with 2 types
GNBTQ Generex Biotechnology Corp.
05/20/2021 9:30:48 AM
as always, Genex has managed to com (2)
GNBTQ Generex Biotechnology Corp.
05/20/2021 1:34:08 AM
summarizing: starting from the 270t
GNBTQ Generex Biotechnology Corp.
05/19/2021 10:22:43 PM
I assume that the class a shares wi
GNBTQ Generex Biotechnology Corp.
05/19/2021 8:06:14 PM
then we explain why nugx is listed (1)
GNBTQ Generex Biotechnology Corp.
05/19/2021 6:27:07 PM
I would like to keep my feet on the (1)
GNBTQ Generex Biotechnology Corp.
05/19/2021 6:20:06 PM
https://www.sec.gov/Archives/edgar (1)
GNBTQ Generex Biotechnology Corp.
05/19/2021 6:18:16 PM
https://www.sec.gov/Archives/edgar (1)
GNBTQ Generex Biotechnology Corp.
05/14/2021 5:30:47 PM
in truth I think that many are wait (3)
GNBTQ Generex Biotechnology Corp.
05/07/2021 3:10:07 AM
Zolis I agree. And I would also add (7)
GNBTQ Generex Biotechnology Corp.
05/06/2021 4:29:45 AM
"YouFeng will have the exclusive sa
GNBTQ Generex Biotechnology Corp.
05/05/2021 4:21:29 PM
another pr that says nothing: "if y (3)
GNBTQ Generex Biotechnology Corp.
04/30/2021 5:02:30 PM
perhaps the turning point lies prec (1)
GNBTQ Generex Biotechnology Corp.
04/30/2021 7:24:08 AM
... if Ngio will be listed (.... wh (5)
GNBTQ Generex Biotechnology Corp.
04/27/2021 10:37:45 AM
"Pursuant to the partnership, the c (1)
GNBTQ Generex Biotechnology Corp.
04/24/2021 4:04:38 AM
I am convinced so. If what has been (5)
GNBTQ Generex Biotechnology Corp.
04/23/2021 1:49:30 PM
ind approval I don't think, ind pre (2)
GNBTQ Generex Biotechnology Corp.
04/21/2021 9:20:19 AM
Unfortunately, with this depressing (2)
GNBTQ Generex Biotechnology Corp.
04/14/2021 12:43:58 PM
the li-key vaccine would appear to (1)
GNBTQ Generex Biotechnology Corp.
04/10/2021 5:36:00 AM
totally agree with Zolis. Given the (6)
GNBTQ Generex Biotechnology Corp.
04/08/2021 5:58:11 PM
it could be, but I don't think Bard (5)
GNBTQ Generex Biotechnology Corp.
04/08/2021 8:12:51 AM
my elderly mother had the second pf
GNBTQ Generex Biotechnology Corp.
03/27/2021 9:55:15 AM
Zolis, the timing is out of control (1)
GNBTQ Generex Biotechnology Corp.
03/26/2021 5:44:14 PM
I imagine that Joe wants to wait, t (4)
GNBTQ Generex Biotechnology Corp.
03/24/2021 6:28:15 AM
March is also going .... and we do (7)
GNBTQ Generex Biotechnology Corp.
03/18/2021 10:23:01 AM
unfortunately this aggressive, some (3)
GNBTQ Generex Biotechnology Corp.
03/17/2021 2:12:56 PM
there is not much more to say: it i (4)
GNBTQ Generex Biotechnology Corp.
03/17/2021 11:03:27 AM
that's what I thought too: no commu (3)
GNBTQ Generex Biotechnology Corp.
03/16/2021 5:44:35 PM
exactly Hylander, here we are liter (4)
GNBTQ Generex Biotechnology Corp.
03/15/2021 12:41:08 PM
sorry but from today ngux is a quot
GNBTQ Generex Biotechnology Corp.
03/10/2021 1:02:35 PM
totally agree. timelines never main (1)
GNBTQ Generex Biotechnology Corp.
03/09/2021 1:49:45 AM
and this worries a lot: lack of new (2)
GNBTQ Generex Biotechnology Corp.
03/03/2021 3:46:57 PM
shareholders have already suffered (2)
GNBTQ Generex Biotechnology Corp.
03/03/2021 3:37:50 PM
and Ngio's listing is the priority: (3)
GNBTQ Generex Biotechnology Corp.
03/03/2021 3:34:52 PM
we went back a few months: dilution (2)
GNBTQ Generex Biotechnology Corp.
03/02/2021 6:51:38 PM
you are not the only one, I bought (1)
GNBTQ Generex Biotechnology Corp.
02/25/2021 6:14:51 PM
the historical shareholder GNBT wil (1)
GNBTQ Generex Biotechnology Corp.
02/24/2021 2:49:10 PM
certainly the excellent news today (3)
GNBTQ Generex Biotechnology Corp.
02/23/2021 6:38:43 PM
the complete vaccine would be neede (2)
GNBTQ Generex Biotechnology Corp.
02/09/2021 7:30:26 PM
interesting to re-read this transcr (4)
GNBTQ Generex Biotechnology Corp.
02/08/2021 1:48:39 PM
true, my confidence is back to zero (2)
GNBTQ Generex Biotechnology Corp.
02/06/2021 2:23:26 AM
interesting data on scientific prog (2)
GNBTQ Generex Biotechnology Corp.
02/06/2021 12:34:40 AM
Rjs thank you very much (2)
GNBTQ Generex Biotechnology Corp.
02/05/2021 1:45:45 PM
Zolis I have the same feeling as yo (1)
GNBTQ Generex Biotechnology Corp.
02/05/2021 11:08:41 AM
it would be great to have such news (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Investors Can Take Charge in RxSight, Inc. Legal Battle
  • Replimune Group, Inc. Investors: Join the Growing Securities Class Action
  • Mineralys Therapeutics Announces Significant Stock Offering
  • Investors Urged to Act on Dow Inc. Class Action Lawsuit
  • Tetra Consultants Welcomes Lester Mok as New Managing Director
  • Tech Giants and Innovative Firms Leading Today's Stock Market Trends
  • Investigation Into National Grid plc: A Call for Investors
  • R2 Capital's Strategic Growth in Office Property Investments
  • TransUnion Faces Investigation Over Massive Data Breach
  • Teck's Action Plan: A Roadmap for Enhanced Operations
  • IRSA Inversiones y Representaciones S.A. Posts Strong FY 2025 Results
  • Rocket Companies Extends Cash Tender Offers for Senior Notes
  • Rocket Companies Extends Exchange Offers for Senior Notes
  • IRSA Inversiones y Representaciones S.A: Strong FY 2025 Results
  • Royalty Pharma Secures $2 Billion in Unsecured Notes Offering
  • Marksmen Energy Inc. Updates on Exploration and Royalties
  • Investors Alert: Capricor Therapeutics Class Action Details
  • Atlanta Beltline, Inc. Celebrated as Top Employer for 2025
  • Atlanta Beltline, Inc. Recognized Again for Best Workplace Excellence
  • Coventry First Challenges Abacus Lawsuit Over Life Settlements
  • Investors Alerted to Lead Plaintiff Deadline in Lineage Case
  • Sable Offshore Corp. Class Action Update for Investors: Key Details
  • Discovering Heavenly Wonders in a Heartwarming New Book
  • Tamarack Resort Welcomes Exciting PGA Pro-Am Golf Tournament
  • Alto Neuroscience Investors Urged to Consider Class Action Options
  • Exploring the Growth Potential of UFP Industries Stock Today
  • CIEE Launches Exciting Environmental Internship in Denmark
  • Eisai Advances LEQEMBI® for Alzheimer's with sBLA to FDA
  • Fortis Inc. Launches $750 Million Subordinated Notes Offering
  • How a $1000 Investment in Targa Resources Could Flourish
  • Guidance on Joining the Easterly ROCMuni Fund Class Action
  • Hamilton Lane Shares Offered: New Opportunities for Investors
  • Saudi Arabia's Dates Market Growth Set for USD 286.29 Million by 2030
  • Eisai's LEQEMBI IQLIK: A Revolutionary Step in Alzheimer's Treatment
  • Revolutionizing Semiconductor Production with High NA EUV Technology
  • Major Federal Settlement Enhances Mental Health Services for Youth
  • Transform Your Investment Journey with EMCOR Group's Gains
  • Thrilling Film on Bitcoin's Mystique and Its Creator's Secret
  • Fortis Inc. Unveils Subordinated Notes Offering for Growth
  • Zscaler's Impressive Fourth Quarter Highlights and Growth Prospects
  • Global Investment Opportunities at the Costa Rica Summit
  • Incredible Growth: How $100 in Intuit Transformed Over Two Decades
  • Desert Financial Ranks Among Best Credit Unions for 2025
  • David Crane Takes Leadership at Generate Capital in Growth Era
  • Legal Guidance Advised for Spectrum Pharmaceuticals Investors
  • Legal Investigation into Corporate Transactions Affecting Shareholders
  • MarineMax, Inc. Faces Fraud Investigation: Key Insights for Investors
  • Exciting Innovations and Experiences Await at Powder Mountain
  • Unlocking AI Utility: Sparkvia Launches SPK Token Sale
  • Exciting Earnings Call Details from Evolution Petroleum Corporation
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site